Literature DB >> 28845053

The Value of Partial HPV Genotyping After Conization of Cervical Dysplasias.

Kristin Friebe1, Rüdiger Klapdor1, Peter Hillemanns1, Matthias Jentschke1.   

Abstract

INTRODUCTION: In this retrospective study partial genotyping of human papilloma viruses (HPV) using the Abbott RealTime HighRisk HPV Test (RealTime) was compared with simple HPV detection (Qiagen Hybrid Capture 2 Test; hc2) for recurrence prediction at the first follow-up examination after conization of cervical intraepithelial neoplasia (CIN).
METHODS: 144 women who had undergone conization for CIN between January 2007 and December 2013 were included. HPV status was determined preoperatively and at first follow-up using hc2 in 103 women and RealTime in 41 women. Recurrent or persistent CIN was assumed when CIN2+ was confirmed histologically or on comparable cytology findings.
RESULTS: Of the 144 women with complete data 12 (8.3%) had a recurrence after conization. HPV persistence at follow-up correlated significantly with recurrence (hc2: p = 0.003; RealTime: p = 0.003) and both sensitivity and specificity were high (hc2 = 100 and 78.4% respectively; RealTime = 75.0 and 83.9%). Whereas isolated HPV testing had a relatively low positive predictive value for recurrence (hc2 16%; RealTime 54.5%), this rose to 80% with HPV 16 detection at follow-up.
CONCLUSION: At follow-up after conization of CIN the combination of high risk HPV detection and partial genotyping of HPV 16 constitutes excellent diagnostic criteria for recurrence/persistence of CIN.

Entities:  

Keywords:  HPV-genotyping; cervical intraepithelial neoplasia; conization; human papilloma virus

Year:  2017        PMID: 28845053      PMCID: PMC5570588          DOI: 10.1055/s-0043-115395

Source DB:  PubMed          Journal:  Geburtshilfe Frauenheilkd        ISSN: 0016-5751            Impact factor:   2.915


  28 in total

1.  Predicting residual disease after excision of cervical dysplasia.

Authors:  Nicholas Johnson; Mansoureh Khalili; Lynn Hirschowitz; Fran Ralli; Richard Porter
Journal:  BJOG       Date:  2003-10       Impact factor: 6.531

Review 2.  HPV testing and monitoring of women after treatment of CIN 3: review of the literature and meta-analysis.

Authors:  G D Zielinski; A G Bais; Th J Helmerhorst; R H M Verheijen; F A de Schipper; P J F Snijders; F J Voorhorst; F J van Kemenade; L Rozendaal; C J L M Meijer
Journal:  Obstet Gynecol Surv       Date:  2004-07       Impact factor: 2.347

Review 3.  The up-to-date evidence on colposcopy practice and treatment of cervical intraepithelial neoplasia: the Cochrane colposcopy & cervical cytopathology collaborative group (C5 group) approach.

Authors:  M Kyrgiou; I Tsoumpou; T Vrekoussis; P Martin-Hirsch; M Arbyn; W Prendiville; S Mitrou; G Koliopoulos; N Dalkalitsis; P Stamatopoulos; E Paraskevaidis
Journal:  Cancer Treat Rev       Date:  2006-09-27       Impact factor: 12.111

4.  Minimal cold knife conization height for high-grade cervical squamous intraepithelial lesion treatment.

Authors:  Lúcia Maria Kliemann; Meiri Silva; Marília Reinheimer; Waldemar A Rivoire; Edison Capp; Ricardo Dos Reis
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2012-09-01       Impact factor: 2.435

5.  Recurrent high-grade cervical lesion after primary conization is associated with persistent human papillomavirus infection in Norway.

Authors:  O K Vintermyr; O Iversen; S Thoresen; W Quint; A Molijn; S de Souza; D Rosillon; K Holl
Journal:  Gynecol Oncol       Date:  2014-03-11       Impact factor: 5.482

6.  Large loop excision of the transformation zone and cervical intraepithelial neoplasia: a 22-year experience.

Authors:  Sofia M Stasinou; George Valasoulis; Maria Kyrgiou; Vasiliki Malamou-Mitsi; Evripidis Bilirakis; Lina Pappa; Emmanouil Deligeoroglou; Maria Nasioutziki; Christina Founta; Alexandros Daponte; George Koliopoulos; Aristotelis Loufopoulos; Petros Karakitsos; Evangelos Paraskevaidis
Journal:  Anticancer Res       Date:  2012-09       Impact factor: 2.480

7.  Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.

Authors:  Silvia de Sanjose; Wim Gv Quint; Laia Alemany; Daan T Geraets; Jo Ellen Klaustermeier; Belen Lloveras; Sara Tous; Ana Felix; Luis Eduardo Bravo; Hai-Rim Shin; Carlos S Vallejos; Patricia Alonso de Ruiz; Marcus Aurelho Lima; Nuria Guimera; Omar Clavero; Maria Alejo; Antonio Llombart-Bosch; Chou Cheng-Yang; Silvio Alejandro Tatti; Elena Kasamatsu; Ermina Iljazovic; Michael Odida; Rodrigo Prado; Muhieddine Seoud; Magdalena Grce; Alp Usubutun; Asha Jain; Gustavo Adolfo Hernandez Suarez; Luis Estuardo Lombardi; Aekunbiola Banjo; Clara Menéndez; Efrén Javier Domingo; Julio Velasco; Ashrafun Nessa; Saibua C Bunnag Chichareon; You Lin Qiao; Enrique Lerma; Suzanne M Garland; Toshiyuki Sasagawa; Annabelle Ferrera; Doudja Hammouda; Luciano Mariani; Adela Pelayo; Ivo Steiner; Esther Oliva; Chris Jlm Meijer; Waleed Fahad Al-Jassar; Eugenia Cruz; Thomas C Wright; Ana Puras; Cecilia Ladines Llave; Maria Tzardi; Theodoros Agorastos; Victoria Garcia-Barriola; Christine Clavel; Jaume Ordi; Miguel Andújar; Xavier Castellsagué; Gloria I Sánchez; Andrzej Marcin Nowakowski; Jacob Bornstein; Nubia Muñoz; F Xavier Bosch
Journal:  Lancet Oncol       Date:  2010-10-15       Impact factor: 41.316

8.  Type-specific HPV geno-typing improves detection of recurrent high-grade cervical neoplasia after conisation.

Authors:  Julie Heymans; Ina H Benoy; Willy Poppe; Christophe E Depuydt
Journal:  Int J Cancer       Date:  2011-02-11       Impact factor: 7.396

9.  Comparison of the clinical performances of the AdvanSure HPV Screening Real-Time PCR, the Abbott Real-Time High-Risk HPV Test, and the Hybrid Capture High-Risk HPV DNA Test for Cervical Cancer Screening.

Authors:  Hae-Sun Chung; Chorong Hahm; Miae Lee
Journal:  J Virol Methods       Date:  2014-05-06       Impact factor: 2.014

10.  Cancer free survival after CIN treatment: comparisons of treatment methods and histology.

Authors:  Ilkka Kalliala; Pekka Nieminen; Tadeusz Dyba; Eero Pukkala; Ahti Anttila
Journal:  Gynecol Oncol       Date:  2007-02-06       Impact factor: 5.482

View more
  4 in total

1.  Association Between Positive Human Papillomavirus Status After Conization and Disease Recurrence in Patients with Cervical Intraepithelial Neoplasia Grade 3.

Authors:  Masaki Kamio; Shintaro Yanazume; Shinichi Togami; Hiroaki Kobayashi
Journal:  J Obstet Gynaecol India       Date:  2020-09-10

2.  Cytology and High-Risk Human Papillomavirus Test for Cervical Cancer Screening Assessment.

Authors:  Frederik A Stuebs; Martin C Koch; Anna K Dietl; Werner Adler; Carol Geppert; Arndt Hartmann; Antje Knöll; Matthias W Beckmann; Grit Mehlhorn; Carla E Schulmeyer; Paul Gass
Journal:  Diagnostics (Basel)       Date:  2022-07-19

3.  A Systematic Review of Tests for Postcolposcopy and Posttreatment Surveillance.

Authors:  Megan A Clarke; Elizabeth R Unger; Rosemary Zuna; Erin Nelson; Teresa M Darragh; Miriam Cremer; Colleen K Stockdale; Mark H Einstein; Nicolas Wentzensen
Journal:  J Low Genit Tract Dis       Date:  2020-04       Impact factor: 3.842

4.  Reporting and Assessing the Quality of Diagnostic Accuracy Studies for Cervical Cancer Screening and Management.

Authors:  Megan A Clarke; Teresa M Darragh; Erin Nelson; Elizabeth R Unger; Rosemary Zuna; Miriam Cremer; Colleen K Stockdale; Mark H Einstein; Nicolas Wentzensen
Journal:  J Low Genit Tract Dis       Date:  2020-04       Impact factor: 3.842

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.